About Turbine
Turbine is a biotechnology AI company that has built a Virtual Lab platform for simulating biological experiments at unprecedented scale. Founded in 2016 and headquartered in Budapest, Hungary, Turbine serves leading biopharma companies including MSD (Merck & Co.), AstraZeneca, Bayer, and Ono Pharmaceutical. The company's platform enables scientists to simulate millions of experiments per day on virtual disease models, dramatically accelerating drug discovery timelines and improving success rates. Turbine's Virtual Lab includes over 1,400 oncology cell lines, 1,200 payloads and drug molecules, and knockout alterations across 8,500+ genes. The platform supports multiple use cases including target discovery, combination design, ADC positioning, biomarker selection, clinical positioning, and indication expansion. By virtualizing experiments before conducting wet lab work, Turbine helps partners make better R&D decisions repeatedly, with claims of 1.5x higher validation success rates and 2x faster timelines from scientific question to validation. The company offers tiered access from self-serve simulations on public datasets (vLab Core) to fully integrated collaborative platforms with proprietary data (vLab Collaborate) and wet lab validation loops. Turbine has raised over $60M in funding through Series B, backed by investors including Accel, MSD Global Health Innovation Fund, XTX Ventures, and Accenture Ventures. The company employs over 80 people across multiple European countries and the United States.
Mission & Story
Mission
Turning biology into an engineering discipline
Founding Story
Founded in 2016 by Nagy Szabolcs (CEO), Dr. Veres Dániel (CSO), Szalay Kristóf (CTO), and Dr. Fekete Iván (Lead Application Scientist)
Clinical Focus
Medical conditions and clinical areas addressed by Turbine.
Who It Serves
Milestones & Awards
Recent Milestones
Raised $25M Series B in February 2024. Partnership with AstraZeneca announced October 2025 for ADC development. Platform validated across 30+ discovery programs.
Key Partnerships
Social & Media
Latest Updates
Company Details
- Founded
- 2016
- Headquarters
- Budapest, Hungary
- Employees
- 51-200
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.